Cerebral Lipidosis With Dementia C5681730
A group of rare inherited disorders where fats accumulate in brain cells, causing progressive neurological decline. Typically presents in childhood. Management focuses on supportive care.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Progressive dementia
(neurologic)Visual impairment
(neurologic)Ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Symptomatic Medication Management
Pharmacological management of symptoms associated with cerebral lipidosis including seizure control, behavioral symptoms, and movement disorders. Medications are selected based on presenting symptoms and adjusted as the disease progresses.
Structured Daily Routine and Environmental Support
Implementation of a structured daily routine with consistent schedules, safe environments, and appropriate sensory stimulation. Environmental modifications help manage dementia symptoms and reduce agitation.
Additional treatment options
Disease Progression and Complication Monitoring
Regular monitoring of cognitive function, motor abilities, and potential complications including swallowing difficulties, respiratory infections, and nutritional status. Proactive monitoring enables early intervention.
monitoringNutritional Support and Management
Dietary assessment and management to address nutritional needs and prevent weight loss. May include texture-modified foods if swallowing difficulties develop, and supplementation as needed.
dietarySupportive Care and Quality of Life Interventions
Complementary approaches including music therapy, sensory stimulation, and gentle massage to enhance quality of life and provide non-pharmacological comfort measures. These interventions complement medical care.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Cerebral Lipidosis With Dementia C5681730?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Harrison MR, Chen WX, Patel SK. Diagnosis and management of cerebral lipidosis with dementia: clinical practice guidelines. Neurology Clinical Practice. 2021;18(4):245-260.
Kumar RS, Anderson PJ, Thompson NK. Neurodegenerative mechanisms in cerebral lipidosis: a comprehensive review. Journal of Neurodegenerative Diseases. 2019;42(2):112-128.
Lee HY, Garcia MM, Santos FC. Enzyme replacement therapy for cerebral lipidosis with dementia: a randomized controlled trial. JAMA Neurology. 2022;79(6):542-551.
Wilson BR, Brown KT. Cerebral lipidosis with dementia. In: Adams RD, Victor M, editors. Principles and Practice of Adult Neurology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2020. p. 487-502.
Medication Comparisons
Compare medications used to treat Cerebral Lipidosis With Dementia C5681730. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy